Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence, Seroconversion and Impact of COVID-19 in Autoimmune Diseases in Europe

NCT04397237 is registered in ClinicalTrials.gov with Pitié-Salpêtrière Hospital as lead sponsor.

NCT NCT04397237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04397237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence, Seroconversion and Impact of COVID-19 in Autoimmune Diseases in Europe
Lead sponsor
Pitié-Salpêtrière Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 10, 2020
Completion date
January 31, 2021
Enrollment
3,100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

axial spondyloarthritis, covid-19, giant cell arteritis, rheumatoid arthritis, sjogren's syndrome, systemic lupus erythematosus